Healthy, no Evidence of Disease Clinical Trial
Official title:
Clinical Study of Resveratrol on Drug and Carcinogen Metabolizing Enzymes
Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it works in healthy adult participants.
PRIMARY OBJECTIVES:
I. To determine the effect of resveratrol on human cytochrome P450 (CYP) enzyme activity in
healthy adult participants.
SECONDARY OBJECTIVES:
I. To determine the modulation effect on phase II detoxification enzymes. II. To evaluate
safety in participants treated with this drug.
OUTLINE:
Participants receive oral resveratrol once daily for 4 weeks.
Patients complete a daily diary documenting adverse events and an intake calendar for
recording the daily intake of any non-routine medications.
Participants undergo blood sample collection periodically. Lymphocytes are isolated and
analyzed for baseline GST activity and level. Serum is analyzed to determine bilirubin
levels to be used as surrogate UGT 1A1 activity. Analyses of CYP probe drugs will be
performed using high performance liquid chromatography (HPLC) assays. A sensitive ELISA
assay will be used for quantitative analyses. Urine samples are collected periodically and
drug and metabolite levels will be analyzed.
After completion of study treatment, participants are followed for 2 weeks.
;
Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01950403 -
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01561989 -
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
|
N/A | |
| Terminated |
NCT01336387 -
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01140646 -
Evaluation of SAMe for Hot Flashes
|
Phase 2 | |
| Completed |
NCT00892515 -
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
|
N/A | |
| Completed |
NCT00365209 -
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
|
Phase 2 | |
| Completed |
NCT00450957 -
Lycopene in Healthy Male Participants
|
Phase 1 | |
| Recruiting |
NCT04445532 -
Hepatobiliary Tumors Tissue Samples Acquisition
|
||
| Completed |
NCT02100254 -
Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities
|
N/A | |
| Completed |
NCT02129517 -
Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials
|
N/A | |
| Terminated |
NCT01755208 -
Light-Scattering Spectroscopy for Detection of Breast Cancer
|
N/A | |
| Completed |
NCT00392652 -
Diindolylmethane in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00499460 -
Effects of Garlic Supplements on Opioids in Healthy Volunteers
|
Phase 4 | |
| Completed |
NCT01077453 -
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
|
Phase 1 | |
| Completed |
NCT00478309 -
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
|
N/A | |
| Completed |
NCT01370889 -
Resveratrol in Postmenopausal Women With High Body Mass Index
|
Phase 1 | |
| Completed |
NCT00896207 -
Studying Different Formulations of SR13668 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00679094 -
Bowman-Birk Inhibitor Concentrate in Healthy Men
|
Phase 1 | |
| Terminated |
NCT02154984 -
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
|
N/A | |
| Completed |
NCT00489372 -
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
|
Phase 1 |